CareFusion: Increased Infusion Sales Offset By Light Flu Season
This article was originally published in The Gray Sheet
Executive Summary
CareFusion had mixed results last quarter, combining increased infusion pump sales offset by reduced respiratory revenues, due, in part, to a lighter flu season, the firm said Nov. 2.
You may also be interested in...
People In Brief
CareFusion
People In Brief
CareFusion
CareFusion Aims To Accelerate Infusion Sales Growth Post Baxter Recall
CareFusion expects to grow infusion system sales at a brisk rate in fiscal 2011, in part by capitalizing on Baxter's ongoing infusion pump recall, the firm said during its Aug. 10 earnings call